Protalix BioTherapeutics
PLX
PLX
31 hedge funds and large institutions have $27.1M invested in Protalix BioTherapeutics in 2015 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 11 increasing their positions, 4 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
33% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 9
51% less call options, than puts
Call options by funds: $43K | Put options by funds: $87K
Holders
31
Holding in Top 10
–
Calls
$43K
Puts
$87K
Top Buyers
| 1 | +$6.12M | |
| 2 | +$3.4M | |
| 3 | +$713K | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$311K |
| 5 |
SIM
Spark Investment Management
New York
|
+$203K |
Top Sellers
| 1 | -$7.67M | |
| 2 | -$2.95M | |
| 3 | -$1.41M | |
| 4 |
MMH
Menora Mivtachim Holdings
Ramat Gan,
Israel
|
-$1.16M |
| 5 |
MTWSIF
Mivtachim The Workers Social Insurance Fund
Tel Aviv,
Israel
|
-$730K |